New patent for Pharmacyclics Inc drug IMBRUVICA
Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are thirty-eight patents…

The post New patent for Pharmacyclics Inc drug IMBRUVICA appeared first on DrugPatentWatch – Make Better Decisions.